nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketamine—CYP2B6—Thiotepa—sarcoma	0.253	0.306	CbGbCtD
Ketamine—PTGS1—Etoposide—sarcoma	0.0899	0.109	CbGbCtD
Ketamine—CYP3A4—Thiotepa—sarcoma	0.0776	0.094	CbGbCtD
Ketamine—ABCB1—Dactinomycin—sarcoma	0.0622	0.0754	CbGbCtD
Ketamine—ABCB1—Mitoxantrone—sarcoma	0.0557	0.0674	CbGbCtD
Ketamine—CYP2C8—Etoposide—sarcoma	0.0519	0.0628	CbGbCtD
Ketamine—CYP2B6—Doxorubicin—sarcoma	0.0467	0.0566	CbGbCtD
Ketamine—ABCB1—Vincristine—sarcoma	0.0383	0.0464	CbGbCtD
Ketamine—ABCB1—Etoposide—sarcoma	0.0351	0.0425	CbGbCtD
Ketamine—CYP3A4—Mitoxantrone—sarcoma	0.0334	0.0404	CbGbCtD
Ketamine—ABCB1—Doxorubicin—sarcoma	0.024	0.029	CbGbCtD
Ketamine—CYP3A4—Vincristine—sarcoma	0.023	0.0278	CbGbCtD
Ketamine—CYP3A4—Etoposide—sarcoma	0.021	0.0255	CbGbCtD
Ketamine—CYP3A4—Doxorubicin—sarcoma	0.0144	0.0174	CbGbCtD
Ketamine—Nystagmus—Vincristine—sarcoma	0.00197	0.0427	CcSEcCtD
Ketamine—Cystitis noninfective—Thiotepa—sarcoma	0.00155	0.0336	CcSEcCtD
Ketamine—Cystitis—Thiotepa—sarcoma	0.00153	0.0332	CcSEcCtD
Ketamine—Laryngospasm—Etoposide—sarcoma	0.00153	0.0331	CcSEcCtD
Ketamine—GRIN3B—testis—sarcoma	0.00147	0.0826	CbGeAlD
Ketamine—Bladder pain—Thiotepa—sarcoma	0.00144	0.0311	CcSEcCtD
Ketamine—Apnoea—Etoposide—sarcoma	0.00135	0.0292	CcSEcCtD
Ketamine—TACR1—hematopoietic system—sarcoma	0.000979	0.0549	CbGeAlD
Ketamine—TACR1—connective tissue—sarcoma	0.000943	0.0528	CbGeAlD
Ketamine—Nystagmus—Epirubicin—sarcoma	0.000895	0.0194	CcSEcCtD
Ketamine—TACR1—smooth muscle tissue—sarcoma	0.000862	0.0483	CbGeAlD
Ketamine—Nystagmus—Doxorubicin—sarcoma	0.000828	0.018	CcSEcCtD
Ketamine—GRIN2D—tendon—sarcoma	0.000795	0.0445	CbGeAlD
Ketamine—Arrhythmia—Thiotepa—sarcoma	0.000712	0.0154	CcSEcCtD
Ketamine—GRIN2C—testis—sarcoma	0.000708	0.0397	CbGeAlD
Ketamine—Bradycardia—Mitoxantrone—sarcoma	0.000701	0.0152	CcSEcCtD
Ketamine—Erythema—Thiotepa—sarcoma	0.000694	0.015	CcSEcCtD
Ketamine—Erythema—Dactinomycin—sarcoma	0.000689	0.0149	CcSEcCtD
Ketamine—GRIN2D—testis—sarcoma	0.000658	0.0369	CbGeAlD
Ketamine—Vision blurred—Thiotepa—sarcoma	0.000654	0.0142	CcSEcCtD
Ketamine—Cystitis noninfective—Epirubicin—sarcoma	0.000624	0.0135	CcSEcCtD
Ketamine—Salivary hypersecretion—Epirubicin—sarcoma	0.000621	0.0135	CcSEcCtD
Ketamine—GRIN3A—testis—sarcoma	0.000619	0.0347	CbGeAlD
Ketamine—Cystitis—Epirubicin—sarcoma	0.000617	0.0134	CcSEcCtD
Ketamine—Arrhythmia—Mitoxantrone—sarcoma	0.000615	0.0133	CcSEcCtD
Ketamine—Convulsion—Thiotepa—sarcoma	0.000601	0.013	CcSEcCtD
Ketamine—Erythema—Mitoxantrone—sarcoma	0.000599	0.013	CcSEcCtD
Ketamine—GRIN2A—tendon—sarcoma	0.000591	0.0331	CbGeAlD
Ketamine—Bladder pain—Epirubicin—sarcoma	0.000578	0.0125	CcSEcCtD
Ketamine—Cystitis noninfective—Doxorubicin—sarcoma	0.000578	0.0125	CcSEcCtD
Ketamine—Salivary hypersecretion—Doxorubicin—sarcoma	0.000574	0.0125	CcSEcCtD
Ketamine—Cystitis—Doxorubicin—sarcoma	0.000571	0.0124	CcSEcCtD
Ketamine—Vision blurred—Mitoxantrone—sarcoma	0.000565	0.0122	CcSEcCtD
Ketamine—OPRM1—hematopoietic system—sarcoma	0.000543	0.0304	CbGeAlD
Ketamine—Anorexia—Thiotepa—sarcoma	0.00054	0.0117	CcSEcCtD
Ketamine—PTGS1—endothelium—sarcoma	0.000539	0.0302	CbGeAlD
Ketamine—TACR1—testis—sarcoma	0.000537	0.0301	CbGeAlD
Ketamine—Anorexia—Dactinomycin—sarcoma	0.000536	0.0116	CcSEcCtD
Ketamine—CYP2C8—mammary gland—sarcoma	0.000536	0.03	CbGeAlD
Ketamine—Bladder pain—Doxorubicin—sarcoma	0.000535	0.0116	CcSEcCtD
Ketamine—Convulsion—Vincristine—sarcoma	0.000533	0.0116	CcSEcCtD
Ketamine—Convulsion—Mitoxantrone—sarcoma	0.000519	0.0113	CcSEcCtD
Ketamine—Anaphylactic shock—Vincristine—sarcoma	0.000502	0.0109	CcSEcCtD
Ketamine—Decreased appetite—Thiotepa—sarcoma	0.000492	0.0107	CcSEcCtD
Ketamine—Anaphylactic shock—Mitoxantrone—sarcoma	0.000489	0.0106	CcSEcCtD
Ketamine—GRIN2A—testis—sarcoma	0.000489	0.0274	CbGeAlD
Ketamine—Decreased appetite—Dactinomycin—sarcoma	0.000489	0.0106	CcSEcCtD
Ketamine—Pain—Thiotepa—sarcoma	0.000484	0.0105	CcSEcCtD
Ketamine—Shock—Mitoxantrone—sarcoma	0.000481	0.0104	CcSEcCtD
Ketamine—Pain—Dactinomycin—sarcoma	0.000481	0.0104	CcSEcCtD
Ketamine—Anorexia—Vincristine—sarcoma	0.000479	0.0104	CcSEcCtD
Ketamine—CYP2C9—mammary gland—sarcoma	0.000476	0.0267	CbGeAlD
Ketamine—Hypotension—Vincristine—sarcoma	0.000469	0.0102	CcSEcCtD
Ketamine—Anorexia—Mitoxantrone—sarcoma	0.000466	0.0101	CcSEcCtD
Ketamine—Diplopia—Epirubicin—sarcoma	0.000464	0.0101	CcSEcCtD
Ketamine—Hypotension—Mitoxantrone—sarcoma	0.000457	0.00991	CcSEcCtD
Ketamine—Decreased appetite—Vincristine—sarcoma	0.000437	0.00947	CcSEcCtD
Ketamine—Convulsion—Etoposide—sarcoma	0.000432	0.00936	CcSEcCtD
Ketamine—Pain—Vincristine—sarcoma	0.00043	0.00931	CcSEcCtD
Ketamine—Diplopia—Doxorubicin—sarcoma	0.000429	0.00931	CcSEcCtD
Ketamine—Decreased appetite—Mitoxantrone—sarcoma	0.000425	0.00922	CcSEcCtD
Ketamine—Pain—Mitoxantrone—sarcoma	0.000418	0.00907	CcSEcCtD
Ketamine—Anaphylactic shock—Etoposide—sarcoma	0.000407	0.00882	CcSEcCtD
Ketamine—TACR1—lymph node—sarcoma	0.000389	0.0218	CbGeAlD
Ketamine—Anorexia—Etoposide—sarcoma	0.000388	0.00841	CcSEcCtD
Ketamine—Hypotension—Etoposide—sarcoma	0.00038	0.00824	CcSEcCtD
Ketamine—Vomiting—Thiotepa—sarcoma	0.00036	0.00781	CcSEcCtD
Ketamine—Vomiting—Dactinomycin—sarcoma	0.000357	0.00775	CcSEcCtD
Ketamine—Rash—Thiotepa—sarcoma	0.000357	0.00774	CcSEcCtD
Ketamine—Dermatitis—Thiotepa—sarcoma	0.000357	0.00774	CcSEcCtD
Ketamine—Rash—Dactinomycin—sarcoma	0.000354	0.00768	CcSEcCtD
Ketamine—Decreased appetite—Etoposide—sarcoma	0.000354	0.00767	CcSEcCtD
Ketamine—Pain—Etoposide—sarcoma	0.000348	0.00754	CcSEcCtD
Ketamine—Nausea—Thiotepa—sarcoma	0.000336	0.00729	CcSEcCtD
Ketamine—Nausea—Dactinomycin—sarcoma	0.000334	0.00724	CcSEcCtD
Ketamine—Bradycardia—Epirubicin—sarcoma	0.000327	0.00708	CcSEcCtD
Ketamine—CYP2C8—hematopoietic system—sarcoma	0.000326	0.0183	CbGeAlD
Ketamine—Vomiting—Vincristine—sarcoma	0.000319	0.00692	CcSEcCtD
Ketamine—Rash—Vincristine—sarcoma	0.000317	0.00687	CcSEcCtD
Ketamine—Dermatitis—Vincristine—sarcoma	0.000316	0.00686	CcSEcCtD
Ketamine—Vomiting—Mitoxantrone—sarcoma	0.000311	0.00674	CcSEcCtD
Ketamine—Rash—Mitoxantrone—sarcoma	0.000308	0.00669	CcSEcCtD
Ketamine—Dermatitis—Mitoxantrone—sarcoma	0.000308	0.00668	CcSEcCtD
Ketamine—Bradycardia—Doxorubicin—sarcoma	0.000302	0.00656	CcSEcCtD
Ketamine—Nausea—Vincristine—sarcoma	0.000298	0.00647	CcSEcCtD
Ketamine—OPRM1—testis—sarcoma	0.000297	0.0167	CbGeAlD
Ketamine—CYP2B6—hematopoietic system—sarcoma	0.000293	0.0164	CbGeAlD
Ketamine—Nausea—Mitoxantrone—sarcoma	0.000291	0.0063	CcSEcCtD
Ketamine—CYP2C9—hematopoietic system—sarcoma	0.00029	0.0162	CbGeAlD
Ketamine—Arrhythmia—Epirubicin—sarcoma	0.000287	0.00622	CcSEcCtD
Ketamine—Erythema—Epirubicin—sarcoma	0.000279	0.00606	CcSEcCtD
Ketamine—PTGS1—seminal vesicle—sarcoma	0.000278	0.0156	CbGeAlD
Ketamine—Arrhythmia—Doxorubicin—sarcoma	0.000265	0.00575	CcSEcCtD
Ketamine—PTGS1—hematopoietic system—sarcoma	0.000265	0.0148	CbGeAlD
Ketamine—Vision blurred—Epirubicin—sarcoma	0.000263	0.00571	CcSEcCtD
Ketamine—Vomiting—Etoposide—sarcoma	0.000259	0.00561	CcSEcCtD
Ketamine—Erythema—Doxorubicin—sarcoma	0.000259	0.00561	CcSEcCtD
Ketamine—Rash—Etoposide—sarcoma	0.000257	0.00556	CcSEcCtD
Ketamine—Dermatitis—Etoposide—sarcoma	0.000256	0.00556	CcSEcCtD
Ketamine—PTGS1—connective tissue—sarcoma	0.000255	0.0143	CbGeAlD
Ketamine—CYP2B6—skin of body—sarcoma	0.000255	0.0143	CbGeAlD
Ketamine—Vision blurred—Doxorubicin—sarcoma	0.000244	0.00528	CcSEcCtD
Ketamine—Convulsion—Epirubicin—sarcoma	0.000242	0.00525	CcSEcCtD
Ketamine—Nausea—Etoposide—sarcoma	0.000242	0.00524	CcSEcCtD
Ketamine—PTGS1—smooth muscle tissue—sarcoma	0.000233	0.0131	CbGeAlD
Ketamine—PTGS1—skin of body—sarcoma	0.00023	0.0129	CbGeAlD
Ketamine—Anaphylactic shock—Epirubicin—sarcoma	0.000228	0.00494	CcSEcCtD
Ketamine—Shock—Epirubicin—sarcoma	0.000224	0.00486	CcSEcCtD
Ketamine—Convulsion—Doxorubicin—sarcoma	0.000224	0.00486	CcSEcCtD
Ketamine—CYP3A4—hematopoietic system—sarcoma	0.000221	0.0124	CbGeAlD
Ketamine—SLC6A2—testis—sarcoma	0.000218	0.0122	CbGeAlD
Ketamine—Anorexia—Epirubicin—sarcoma	0.000217	0.00471	CcSEcCtD
Ketamine—Hypotension—Epirubicin—sarcoma	0.000213	0.00462	CcSEcCtD
Ketamine—Anaphylactic shock—Doxorubicin—sarcoma	0.000211	0.00457	CcSEcCtD
Ketamine—Shock—Doxorubicin—sarcoma	0.000208	0.0045	CcSEcCtD
Ketamine—CYP2B6—lymphoid tissue—sarcoma	0.000206	0.0116	CbGeAlD
Ketamine—Anorexia—Doxorubicin—sarcoma	0.000201	0.00436	CcSEcCtD
Ketamine—PTGS1—cardiac atrium—sarcoma	0.000201	0.0113	CbGeAlD
Ketamine—PTGS1—uterus—sarcoma	0.0002	0.0112	CbGeAlD
Ketamine—DRD2—testis—sarcoma	0.000198	0.0111	CbGeAlD
Ketamine—Decreased appetite—Epirubicin—sarcoma	0.000198	0.0043	CcSEcCtD
Ketamine—Hypotension—Doxorubicin—sarcoma	0.000197	0.00427	CcSEcCtD
Ketamine—Pain—Epirubicin—sarcoma	0.000195	0.00423	CcSEcCtD
Ketamine—Decreased appetite—Doxorubicin—sarcoma	0.000183	0.00398	CcSEcCtD
Ketamine—ABCB1—myometrium—sarcoma	0.000182	0.0102	CbGeAlD
Ketamine—Pain—Doxorubicin—sarcoma	0.00018	0.00391	CcSEcCtD
Ketamine—CYP2C8—testis—sarcoma	0.000179	0.01	CbGeAlD
Ketamine—ABCB1—embryo—sarcoma	0.000175	0.00982	CbGeAlD
Ketamine—PTGS1—tendon—sarcoma	0.000175	0.00982	CbGeAlD
Ketamine—CYP2C8—liver—sarcoma	0.000169	0.00948	CbGeAlD
Ketamine—ABCB1—seminal vesicle—sarcoma	0.000165	0.00923	CbGeAlD
Ketamine—CYP2B6—testis—sarcoma	0.00016	0.00899	CbGeAlD
Ketamine—SLC6A2—lymph node—sarcoma	0.000158	0.00884	CbGeAlD
Ketamine—ABCB1—hematopoietic system—sarcoma	0.000156	0.00877	CbGeAlD
Ketamine—CYP2B6—liver—sarcoma	0.000152	0.0085	CbGeAlD
Ketamine—CYP2C9—liver—sarcoma	0.00015	0.00842	CbGeAlD
Ketamine—PTGS1—testis—sarcoma	0.000145	0.00813	CbGeAlD
Ketamine—Vomiting—Epirubicin—sarcoma	0.000145	0.00314	CcSEcCtD
Ketamine—Rash—Epirubicin—sarcoma	0.000144	0.00312	CcSEcCtD
Ketamine—Dermatitis—Epirubicin—sarcoma	0.000144	0.00311	CcSEcCtD
Ketamine—Nausea—Epirubicin—sarcoma	0.000135	0.00294	CcSEcCtD
Ketamine—Vomiting—Doxorubicin—sarcoma	0.000134	0.00291	CcSEcCtD
Ketamine—Rash—Doxorubicin—sarcoma	0.000133	0.00288	CcSEcCtD
Ketamine—Dermatitis—Doxorubicin—sarcoma	0.000133	0.00288	CcSEcCtD
Ketamine—GRIN2C—Neuronal System—HRAS—sarcoma	0.000126	0.00115	CbGpPWpGaD
Ketamine—OPRM1—TCR Signaling Pathway—HRAS—sarcoma	0.000126	0.00114	CbGpPWpGaD
Ketamine—GRIN2A—Transmission across Chemical Synapses—HRAS—sarcoma	0.000126	0.00114	CbGpPWpGaD
Ketamine—Nausea—Doxorubicin—sarcoma	0.000125	0.00272	CcSEcCtD
Ketamine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—sarcoma	0.000122	0.00111	CbGpPWpGaD
Ketamine—ABCB1—HIF-1-alpha transcription factor network—JUN—sarcoma	0.00012	0.00109	CbGpPWpGaD
Ketamine—ABCB1—uterus—sarcoma	0.000118	0.00662	CbGeAlD
Ketamine—GRIN2D—Neuronal System—HRAS—sarcoma	0.000117	0.00107	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—CREB1—sarcoma	0.000117	0.00106	CbGpPWpGaD
Ketamine—CYP3A4—liver—sarcoma	0.000115	0.00642	CbGeAlD
Ketamine—GRIN2B—Developmental Biology—CREB1—sarcoma	0.000114	0.00104	CbGpPWpGaD
Ketamine—CYP3A4—Tryptophan metabolism—MDM2—sarcoma	0.000113	0.00103	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—FLT1—sarcoma	0.000112	0.00101	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—CXCR4—sarcoma	0.000111	0.00101	CbGpPWpGaD
Ketamine—DRD2—Circadian rythm related genes—CREB1—sarcoma	0.00011	0.001	CbGpPWpGaD
Ketamine—DRD2—GPCR ligand binding—CXCR4—sarcoma	0.00011	0.001	CbGpPWpGaD
Ketamine—ABCB1—lymphoid tissue—sarcoma	0.00011	0.00617	CbGeAlD
Ketamine—TACR1—Signaling Pathways—PLCG1—sarcoma	0.00011	0.000997	CbGpPWpGaD
Ketamine—GRIN1—Transmission across Chemical Synapses—HRAS—sarcoma	0.00011	0.000996	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—MMP2—sarcoma	0.000109	0.000991	CbGpPWpGaD
Ketamine—GRIN2B—Transmission across Chemical Synapses—HRAS—sarcoma	0.000107	0.000971	CbGpPWpGaD
Ketamine—ABCB1—Allograft Rejection—IL2—sarcoma	0.000107	0.000968	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—MMP2—sarcoma	0.000106	0.000966	CbGpPWpGaD
Ketamine—GRIN1—Axon guidance—SRC—sarcoma	0.000106	0.000962	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—CXCR4—sarcoma	0.000106	0.000958	CbGpPWpGaD
Ketamine—PTGS1—lymph node—sarcoma	0.000105	0.00589	CbGeAlD
Ketamine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—sarcoma	0.000105	0.00095	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—ATF1—sarcoma	0.000104	0.000947	CbGpPWpGaD
Ketamine—GRIN2B—Axon guidance—SRC—sarcoma	0.000103	0.000938	CbGpPWpGaD
Ketamine—GRIN1—Axon guidance—VEGFA—sarcoma	0.000103	0.000937	CbGpPWpGaD
Ketamine—GRIN1—Axon guidance—NRAS—sarcoma	0.000102	0.000925	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—CXCR4—sarcoma	0.000101	0.000914	CbGpPWpGaD
Ketamine—GRIN2B—Axon guidance—VEGFA—sarcoma	0.000101	0.000913	CbGpPWpGaD
Ketamine—ABCB1—bone marrow—sarcoma	0.0001	0.00562	CbGeAlD
Ketamine—GRIN2B—Axon guidance—NRAS—sarcoma	9.94e-05	0.000902	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—CXCR4—sarcoma	9.72e-05	0.000882	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—sarcoma	9.65e-05	0.000876	CbGpPWpGaD
Ketamine—GRIN2A—Neuronal System—HRAS—sarcoma	9.64e-05	0.000875	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—CREB1—sarcoma	9.57e-05	0.000869	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—TLE1—sarcoma	9.34e-05	0.000847	CbGpPWpGaD
Ketamine—GRIN1—Axon guidance—EGFR—sarcoma	9.29e-05	0.000843	CbGpPWpGaD
Ketamine—ABCB1—Allograft Rejection—VEGFA—sarcoma	9.07e-05	0.000823	CbGpPWpGaD
Ketamine—GRIN2B—Axon guidance—EGFR—sarcoma	9.06e-05	0.000822	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—CXCR4—sarcoma	8.83e-05	0.000801	CbGpPWpGaD
Ketamine—GRIN1—Axon guidance—KRAS—sarcoma	8.78e-05	0.000796	CbGpPWpGaD
Ketamine—ABCB1—testis—sarcoma	8.57e-05	0.00481	CbGeAlD
Ketamine—GRIN2B—Axon guidance—KRAS—sarcoma	8.55e-05	0.000776	CbGpPWpGaD
Ketamine—GRIN1—Neuronal System—HRAS—sarcoma	8.41e-05	0.000763	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—CTNNB1—sarcoma	8.37e-05	0.000759	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—CXCR4—sarcoma	8.21e-05	0.000746	CbGpPWpGaD
Ketamine—GRIN2B—Neuronal System—HRAS—sarcoma	8.2e-05	0.000744	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—IGF1R—sarcoma	8.19e-05	0.000743	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—TLE1—sarcoma	8.19e-05	0.000743	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—CTNNB1—sarcoma	8.16e-05	0.00074	CbGpPWpGaD
Ketamine—ABCB1—liver—sarcoma	8.11e-05	0.00454	CbGeAlD
Ketamine—DRD2—Circadian rythm related genes—JUN—sarcoma	7.94e-05	0.000721	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—VEGFC—sarcoma	7.88e-05	0.000715	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—FOXO1—sarcoma	7.8e-05	0.000708	CbGpPWpGaD
Ketamine—TACR1—GPCR downstream signaling—IL2—sarcoma	7.79e-05	0.000707	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—PDGFRB—sarcoma	7.78e-05	0.000706	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—PDGFRA—sarcoma	7.66e-05	0.000695	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—SRC—sarcoma	7.56e-05	0.000686	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—CXCR4—sarcoma	7.46e-05	0.000677	CbGpPWpGaD
Ketamine—GRIN1—Axon guidance—HRAS—sarcoma	7.46e-05	0.000677	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—SRC—sarcoma	7.37e-05	0.000669	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—VEGFA—sarcoma	7.37e-05	0.000669	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—NRAS—sarcoma	7.28e-05	0.00066	CbGpPWpGaD
Ketamine—GRIN2B—Axon guidance—HRAS—sarcoma	7.27e-05	0.00066	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—VEGFA—sarcoma	7.18e-05	0.000652	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	7.12e-05	0.000646	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—NRAS—sarcoma	7.09e-05	0.000644	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—IL2—sarcoma	7.08e-05	0.000642	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—TLE1—sarcoma	6.92e-05	0.000628	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—VEGFC—sarcoma	6.91e-05	0.000627	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—EGFR—sarcoma	6.63e-05	0.000602	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—EGFR—sarcoma	6.46e-05	0.000587	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—KDR—sarcoma	6.45e-05	0.000585	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—FLT1—sarcoma	6.3e-05	0.000571	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—KRAS—sarcoma	6.26e-05	0.000568	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—CXCR4—sarcoma	6.23e-05	0.000565	CbGpPWpGaD
Ketamine—ABCB1—lymph node—sarcoma	6.22e-05	0.00348	CbGeAlD
Ketamine—OPRD1—Signaling Pathways—PLCG1—sarcoma	6.19e-05	0.000562	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—KRAS—sarcoma	6.1e-05	0.000554	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CXCR4—sarcoma	5.95e-05	0.00054	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—KIT—sarcoma	5.94e-05	0.000539	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—NRAS—sarcoma	5.94e-05	0.000539	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	5.89e-05	0.000535	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—ATF1—sarcoma	5.88e-05	0.000534	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—VEGFC—sarcoma	5.84e-05	0.00053	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—CREB1—sarcoma	5.65e-05	0.000513	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—CXCR4—sarcoma	5.65e-05	0.000513	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—FLT1—sarcoma	5.52e-05	0.000501	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—PLCG1—sarcoma	5.43e-05	0.000493	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—EGFR—sarcoma	5.41e-05	0.000491	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—CREB1—sarcoma	5.39e-05	0.000489	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—ENO2—sarcoma	5.39e-05	0.000489	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—HBA1—sarcoma	5.36e-05	0.000486	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—HRAS—sarcoma	5.32e-05	0.000483	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—TLE1—sarcoma	5.24e-05	0.000476	CbGpPWpGaD
Ketamine—DRD2—Circadian rythm related genes—TP53—sarcoma	5.24e-05	0.000476	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CXCR4—sarcoma	5.21e-05	0.000473	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—HRAS—sarcoma	5.19e-05	0.000471	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—ATF1—sarcoma	5.16e-05	0.000468	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	5.13e-05	0.000466	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	5.12e-05	0.000465	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—KRAS—sarcoma	5.11e-05	0.000464	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	5.08e-05	0.000461	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—CREB1—sarcoma	4.73e-05	0.000429	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—MDM2—sarcoma	4.68e-05	0.000425	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—FLT1—sarcoma	4.67e-05	0.000424	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—IGF1R—sarcoma	4.61e-05	0.000419	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	4.59e-05	0.000417	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—PLCG1—sarcoma	4.59e-05	0.000416	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—PLCG1—sarcoma	4.57e-05	0.000415	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	4.47e-05	0.000406	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—VEGFC—sarcoma	4.42e-05	0.000401	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CXCR4—sarcoma	4.41e-05	0.0004	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—FOXO1—sarcoma	4.39e-05	0.000399	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—IL2—sarcoma	4.39e-05	0.000398	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—PDGFRB—sarcoma	4.38e-05	0.000398	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—ATF1—sarcoma	4.36e-05	0.000395	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—HRAS—sarcoma	4.35e-05	0.000394	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—PDGFRA—sarcoma	4.32e-05	0.000392	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—IL2—sarcoma	4.18e-05	0.000379	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	4.12e-05	0.000374	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—ENO2—sarcoma	4.11e-05	0.000373	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—HBA1—sarcoma	4.09e-05	0.000371	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—CCND1—sarcoma	4.08e-05	0.00037	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—JUN—sarcoma	4.07e-05	0.000369	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—IGF1R—sarcoma	4.05e-05	0.000367	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—CTNNB1—sarcoma	4.04e-05	0.000366	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	4.03e-05	0.000365	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—CREB1—sarcoma	4e-05	0.000363	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—IL2—sarcoma	3.99e-05	0.000362	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—FOXO1—sarcoma	3.85e-05	0.00035	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—IL2—sarcoma	3.85e-05	0.000349	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—PDGFRB—sarcoma	3.84e-05	0.000349	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	3.8e-05	0.000345	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—PDGFRA—sarcoma	3.78e-05	0.000343	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—SRC—sarcoma	3.65e-05	0.000331	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—KDR—sarcoma	3.63e-05	0.00033	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—VEGFA—sarcoma	3.55e-05	0.000322	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—FLT1—sarcoma	3.54e-05	0.000321	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—NRAS—sarcoma	3.51e-05	0.000319	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—IL2—sarcoma	3.5e-05	0.000317	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PLCG1—sarcoma	3.49e-05	0.000317	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—ENO2—sarcoma	3.48e-05	0.000316	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PLCG1—sarcoma	3.48e-05	0.000315	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—HBA1—sarcoma	3.46e-05	0.000314	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—IGF1R—sarcoma	3.42e-05	0.00031	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	3.38e-05	0.000307	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—KIT—sarcoma	3.35e-05	0.000304	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—NRAS—sarcoma	3.35e-05	0.000304	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CXCR4—sarcoma	3.34e-05	0.000303	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—ATF1—sarcoma	3.3e-05	0.0003	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—MYC—sarcoma	3.27e-05	0.000297	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—FOXO1—sarcoma	3.25e-05	0.000295	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—IL2—sarcoma	3.25e-05	0.000295	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—PDGFRB—sarcoma	3.25e-05	0.000295	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—PDGFRA—sarcoma	3.2e-05	0.00029	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—EGFR—sarcoma	3.2e-05	0.00029	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CREB1—sarcoma	3.19e-05	0.000289	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—KDR—sarcoma	3.19e-05	0.000289	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—EGFR—sarcoma	3.05e-05	0.000277	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—ENO2—sarcoma	3.03e-05	0.000275	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—CREB1—sarcoma	3.03e-05	0.000275	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—KRAS—sarcoma	3.02e-05	0.000274	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—HBA1—sarcoma	3.01e-05	0.000274	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—IL2—sarcoma	2.95e-05	0.000268	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PLCG1—sarcoma	2.95e-05	0.000268	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—KIT—sarcoma	2.93e-05	0.000266	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—NRAS—sarcoma	2.93e-05	0.000266	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—KRAS—sarcoma	2.88e-05	0.000261	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—ENO2—sarcoma	2.83e-05	0.000257	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—HBA1—sarcoma	2.82e-05	0.000256	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CREB1—sarcoma	2.79e-05	0.000253	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—KDR—sarcoma	2.69e-05	0.000244	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—TP53—sarcoma	2.68e-05	0.000244	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—EGFR—sarcoma	2.67e-05	0.000243	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—MDM2—sarcoma	2.64e-05	0.000239	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—IGF1R—sarcoma	2.59e-05	0.000235	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PLCG1—sarcoma	2.57e-05	0.000234	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—HRAS—sarcoma	2.57e-05	0.000233	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—KRAS—sarcoma	2.53e-05	0.000229	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—KIT—sarcoma	2.48e-05	0.000225	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—NRAS—sarcoma	2.48e-05	0.000225	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—FOXO1—sarcoma	2.47e-05	0.000224	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—IL2—sarcoma	2.47e-05	0.000224	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PDGFRB—sarcoma	2.46e-05	0.000223	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—HRAS—sarcoma	2.45e-05	0.000222	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PDGFRA—sarcoma	2.42e-05	0.00022	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PLCG1—sarcoma	2.4e-05	0.000218	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CREB1—sarcoma	2.36e-05	0.000214	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—IL2—sarcoma	2.35e-05	0.000214	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—MDM2—sarcoma	2.31e-05	0.00021	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CCND1—sarcoma	2.3e-05	0.000208	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—JUN—sarcoma	2.29e-05	0.000208	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CTNNB1—sarcoma	2.27e-05	0.000206	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—EGFR—sarcoma	2.26e-05	0.000205	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—IL2—sarcoma	2.24e-05	0.000203	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—HRAS—sarcoma	2.15e-05	0.000195	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—KRAS—sarcoma	2.13e-05	0.000194	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—IL2—sarcoma	2.06e-05	0.000187	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—SRC—sarcoma	2.05e-05	0.000186	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—KDR—sarcoma	2.04e-05	0.000185	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CCND1—sarcoma	2.01e-05	0.000183	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—JUN—sarcoma	2.01e-05	0.000182	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—VEGFA—sarcoma	2e-05	0.000182	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CTNNB1—sarcoma	1.99e-05	0.000181	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—NRAS—sarcoma	1.98e-05	0.000179	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—MDM2—sarcoma	1.95e-05	0.000177	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—KIT—sarcoma	1.88e-05	0.000171	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—NRAS—sarcoma	1.88e-05	0.000171	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—ENO2—sarcoma	1.87e-05	0.00017	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—HBA1—sarcoma	1.86e-05	0.000169	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—MYC—sarcoma	1.84e-05	0.000167	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—HRAS—sarcoma	1.81e-05	0.000165	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—SRC—sarcoma	1.8e-05	0.000164	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—EGFR—sarcoma	1.8e-05	0.000163	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CREB1—sarcoma	1.79e-05	0.000162	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—VEGFA—sarcoma	1.75e-05	0.000159	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—IL2—sarcoma	1.75e-05	0.000158	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—NRAS—sarcoma	1.73e-05	0.000157	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—EGFR—sarcoma	1.71e-05	0.000155	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—KRAS—sarcoma	1.7e-05	0.000154	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CCND1—sarcoma	1.7e-05	0.000154	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—JUN—sarcoma	1.7e-05	0.000154	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CTNNB1—sarcoma	1.68e-05	0.000153	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—KRAS—sarcoma	1.62e-05	0.000147	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—MYC—sarcoma	1.61e-05	0.000147	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PLCG1—sarcoma	1.59e-05	0.000144	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—EGFR—sarcoma	1.58e-05	0.000143	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—SRC—sarcoma	1.52e-05	0.000138	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—TP53—sarcoma	1.51e-05	0.000137	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—KRAS—sarcoma	1.49e-05	0.000135	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—VEGFA—sarcoma	1.48e-05	0.000135	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—MDM2—sarcoma	1.48e-05	0.000134	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—NRAS—sarcoma	1.46e-05	0.000133	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—HRAS—sarcoma	1.45e-05	0.000131	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—HRAS—sarcoma	1.37e-05	0.000125	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—MYC—sarcoma	1.36e-05	0.000124	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—EGFR—sarcoma	1.33e-05	0.000121	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—TP53—sarcoma	1.33e-05	0.00012	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—IL2—sarcoma	1.32e-05	0.00012	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CCND1—sarcoma	1.29e-05	0.000117	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—JUN—sarcoma	1.29e-05	0.000117	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CTNNB1—sarcoma	1.28e-05	0.000116	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—HRAS—sarcoma	1.27e-05	0.000115	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—KRAS—sarcoma	1.26e-05	0.000114	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—SRC—sarcoma	1.15e-05	0.000105	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—VEGFA—sarcoma	1.12e-05	0.000102	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—TP53—sarcoma	1.12e-05	0.000102	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—NRAS—sarcoma	1.11e-05	0.000101	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—HRAS—sarcoma	1.07e-05	9.73e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—MYC—sarcoma	1.03e-05	9.39e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—EGFR—sarcoma	1.01e-05	9.18e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—KRAS—sarcoma	9.56e-06	8.67e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—TP53—sarcoma	8.49e-06	7.71e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—HRAS—sarcoma	8.12e-06	7.37e-05	CbGpPWpGaD
